| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 103745-39-7 | 1-(5-硫代異喹啉)哌嗪二鹽酸鹽; 鹽酸法舒地爾; 六氫-1-(5-異喹啉磺�；�)-1H-1,4-二氮雜卓鹽酸鹽 | Fasudil; Fasudil HCl; 1H-1,4-Diazepine,hexahydro-1-(5-isoquinolinylsulfonyl)- (9CI); 1-(5-Isoquinolinesulphonyl)homopiperazine; AT 877; Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine; HA 1077; |  | C14H17N3O2S | 詳情 | 供應(yīng)商 |
| 84477-87-2 | Isoquinoline,5-[(2-methyl-1-piperazinyl)sulfonyl]-; Piperazine,1-(5-isoquinolinylsulfonyl)-2-methyl- (9CI); 1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine; H 7; Protein kinase inhibitorH7 |  | C14H17N3O2S | 詳情 | 供應(yīng)商 | |
| 84477-73-6 | Isoquinoline,5-[(3-methyl-1-piperazinyl)sulfonyl]-; Piperazine,1-(5-isoquinolinylsulfonyl)-3-methyl- (9CI); H 71; iso-H 7 |  | C14H17N3O2S | 詳情 | 供應(yīng)商 | |
| 128554-85-8 | 1-Pyrrolidineethanamine,N-(2-nitrobenzo[b]thien-3-yl)-; Benzo[b]thiophen-3-amine,2-nitro-N-[2-(1-pyrrolidinyl)ethyl]- (9CI) |  | C14H17N3O2S | 詳情 | 供應(yīng)商 | |
| 910037-27-3 | 4-Piperidinecarboxylicacid, 1-thieno[3,2-d]pyrimidin-4-yl-, ethyl ester |  | C14H17N3O2S | 詳情 | 供應(yīng)商 | |
| 936233-17-9 | (R)-Isoquinoline-5-sulfonic acid (pyrro lidin-2-ylmethyl)-amide |  | C14H17N3O2S | 詳情 | 供應(yīng)商 |